Francesca D'onofrio

Foggia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Erdheim-Chester disease: A case report emphasizing diagnostic challenges and differential diagnosis.

Erdheim-Chester disease: A case report emphasizing diagnostic challenges and differential diagnosis.

Journal: International journal of rheumatic diseases

Published: January 09, 2024

Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study.

Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study.

Journal: Vaccines

Published: April 26, 2021

Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients.

Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients.

Journal: Clinical and experimental rheumatology

Published: September 02, 2018

Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE).

Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE).

Journal: Clinical rheumatology

Published: February 22, 2018

Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE).

Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE).

Journal: Clinical rheumatology

Published: December 19, 2017

Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

Journal: Medicine

Published: October 20, 2017

Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis.

Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis.

Journal: International journal of immunopathology and pharmacology

Published: June 13, 2017

Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.

Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.

Journal: Seminars in arthritis and rheumatism

Published: October 23, 2016

Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study.

Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study.

Journal: Clinical rheumatology

Published: August 01, 2016

Metabolic syndrome and chronic arthritis: effects of anti-TNF-α therapy.

Metabolic syndrome and chronic arthritis: effects of anti-TNF-α therapy.

Journal: Clinical and experimental medicine

Published: September 08, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026